Itafos Inc. (TSX-V: IFOS) (the "Company”) today reported its Q4 2024 and full year 2024 financial results and provided a corporate update. The Company's financial statements and management's ...
Pieridae Energy Limited ("Pieridae" or the "Company") announces the release of its fourth quarter and full year 2024 financial and operating results and year-end reserves. Pieridae generated Net ...
Where do you go where it's warm in the winter, the food is good (and not too expensive) and the trails are amazing? Mexico?
CNN on MSN8d
Trump imposes sweeping 25% steel and aluminum tariffs. Canada and Europe swiftly retaliatePresident Donald Trump imposed sweeping 25% tariffs on all steel and aluminum imported into the United States Wednesday.
Medical Properties' debt refinancing risks are mitigated, with new tenants exceeding performance expectations. Read why I remain bullish on MPW stock.
“This year seems to be a banner year for norovirus occurring — there’s a lot of cases being reported,” said Dr. Michael Sweat, the director of the Center for Global Health at the Medical University of ...
A microalgal bloom has been identified as the likely cause of dead wildlife washing up on Fleurieu beaches and surfers experiencing worrying symptoms after emerging from the waters, as Victor Harbor’s ...
As steep tariffs on Canadian goods took effect this week, banks on both sides of the border expressed concern about the economic fallout and the uncertainty their customers face.
Quest Products, LLC. (Quest) today announces its acquisition of Beyond Health, P.A. (Beyond Health). Quest is a portfolio company of Promus Equity Partners (Promus). Quest Products LLC, a leader in ...
- German IFO Institute updated its economic forecasts which cut the 2025 GDP growth forecast from 0.4% to 1.1% range to 0.2% ...
A sludge-coloured foam and several dead fish have been sighted on the beaches of Waitpinga Point to Victor Harbor, causing a ...
An ongoing open-label, single arm, POC study is evaluating ANX1502 in patients with cold agglutinin disease (CAD) for up to four weeks to evaluate tolerability, pharmacokinetics, pharmacodynamic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results